Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y011043 | — |
after receiving two doses of Gardasil 9 (Merck/MSD). On both occasions, I developed cellulitis of the finger following the injection; This spontaneous report has been received from a consumer, regarding to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and previous drugs reactions or allergies were not reported. On an unknown date, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) as prophylaxis, lot number Y011043 which had been verified to be a valid number; expiration date reported and upon internal validation established as 05-FEB-2027 (dose, vaccination scheme, route of administration, and anatomical site of injection were not reported). On an unknown date, the patient developed Cellulitis of the finger. At the time of the report the outcome of the event was not provided. The causal relationship between the event and the suspect vaccine was not provided.